Ecklonia cava extract suppresses the high-affinity IgE receptor, FcepsilonRI expression

Area of Science:

• Immunology
• Pharmacology
• Marine Natural Products

Background:

• Basophils and mast cells are key effector cells in allergic reactions.
• These cells express the high-affinity IgE receptor, FcepsilonRI, on their surface.
• Inhibition of FcepsilonRI and downstream signaling can mitigate allergic responses.

Purpose of the Study:

• To investigate the inhibitory effect of Ecklonia cava (EC) methanolic extract on FcepsilonRI expression.
• To determine if EC extract affects IgE binding to FcepsilonRI.
• To assess the impact of EC extract on histamine release.

Main Methods:

• Human basophilic KU812F cells were treated with EC extract.
• Flow cytometry was used to analyze cell surface FcepsilonRI expression and IgE binding.
• RT-PCR was employed to measure FcepsilonRI alpha-chain mRNA levels.
• Fluorescence spectrophotometry quantified histamine release.

Main Results:

• EC extract demonstrated a concentration-dependent reduction in cell surface FcepsilonRI expression.
• The extract inhibited IgE binding to FcepsilonRI.
• EC extract decreased FcepsilonRI alpha-chain mRNA expression.
• Histamine release mediated by FcepsilonRI was significantly inhibited by the extract.

Conclusions:

• EC methanolic extract negatively regulates FcepsilonRI expression in human basophils.
• The extract reduces IgE binding and subsequent histamine release.
• Ecklonia cava extract exhibits potential anti-allergic activity by targeting FcepsilonRI.